Ceftaroline for complicated skin and skin-structure infections

Author： Nannini Esteban C   Stryjewski Martin E   Corey G Ralph  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1197-1206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for complicated skin and skin-structure infections

By Mendoza Natalia   Tyring Stephen K  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 509-520

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin creates a niche in skin and skin-structure infections

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections

By Itani Kamal M.F.  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 421-430

Adis International

Access to resources Recommend Favorite

Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections

By Lodise Thomas P.  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1473-1493

Adis International

Access to resources Recommend Favorite

Moxifloxacin: In Uncomplicated Skin and Skin Structure Infections

By Muijsers R.B.R.   Jarvis B.  

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 967-973

Adis International

Access to resources Recommend Favorite